跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
林 子閔
主治醫師
,
臺北醫學大學附設醫院
https://orcid.org/0000-0002-0370-181X
電子郵件
chateauxjolie
yahoo.com
tw
h-index
341
引文
11
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2012
2023
每年研究成果
概覽
指紋
網路
研究成果
(29)
類似的個人檔案
(10)
指紋
查看啟用 Tzu-Min Lin 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Cohort Analysis
100%
Hazard Ratio
86%
Autoimmune Disease
66%
Autoimmune Rheumatic Disease
50%
Rheumatoid Arthritis
42%
Wearable Sensor
33%
Parkinson's Disease
33%
Infection
29%
Sjoegren Syndrome
27%
Appendectomy
26%
Ankylosing Spondylitis
20%
Biological Product
20%
Disease
18%
Proportional Hazards Model
17%
Transfer of Learning
16%
Chronic Hepatitis C
16%
Raynaud Phenomenon
16%
Ultrasonography
16%
Facial Expression
16%
Spine Fracture
16%
Popliteal Cyst
16%
Allergic Rhinitis
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
COVID-19
16%
Hip Replacement
16%
Pneumocystis Jirovecii
16%
Ischemia
16%
Proton-Pump Inhibitor
16%
Thymectomy
16%
Exercise
16%
Spinal Cord Injury
16%
Upper Limb
16%
Artery Thrombosis
16%
Osteoarthritis
16%
Total Knee Arthroplasty
16%
Tophus
16%
Gout
16%
Middle Age
16%
Body Temperature Measurement
16%
Interferon
16%
Population
13%
Tonsillectomy
10%
Systemic Lupus Erythematosus
9%
Hepatitis C
9%
Medical Instrument
8%
Autoimmunity
8%
Skin Irritation
8%
Immune Function
8%
Immune System
7%
Retrospective Cohort Study
7%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
56%
Autoimmune Disease
50%
Sjoegren Syndrome
37%
Rheumatic Disease
33%
Hepatitis C
25%
Ankylosing Spondylitis
24%
Thyroiditis
18%
Histamine H1 Receptor Antagonist
16%
Liver Cell Carcinoma
16%
Hepatitis B Virus
16%
Randomized Controlled Trial
16%
Hepatitis C Virus
16%
Proton Pump Inhibitor
16%
Jaw Osteonecrosis
16%
Chronic Hepatitis C
16%
Gout
16%
Virus Hepatitis
16%
Indometacin
16%
Bisphosphonic Acid Derivative
16%
Etoricoxib
16%
Pneumocystis Jiroveci
16%
Spinal Cord Injury
16%
Spine Fracture
16%
Parkinson's Disease
16%
Interferon
16%
Systemic Lupus Erythematosus
14%
Antihistaminic Agent
13%
Autoimmune Hemolytic Anemia
13%
Comorbidity
12%
Rheumatoid Arthritis
11%
Infection
10%
Systemic Vasculitis
9%
Myasthenia gravis
7%
Dermatomyositis
6%
Polymyositis
6%
Adverse Event
6%
Addison Disease
5%
Systemic Sclerosis
5%
Spine Injury
5%
Graves Disease
5%
Immunology and Microbiology
Autoimmune Disease
66%
Comorbidity
42%
Sjögren's Syndrome
33%
Autoimmune Rheumatic Disease
33%
Inflammatory Arthritis
29%
Myasthenia gravis
25%
Population
23%
Systemic Lupus Erythematosus
23%
Thyroiditis
19%
Upper Limb
16%
Interferon Type I
16%
Pneumocystis Jiroveci
16%
COVID-19
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Raynaud Phenomenon
16%
Osteoarthritis
16%
Allergic Rhinitis
16%
Gout
16%
Hepatitis C
16%
Autoimmune Hemolytic Anemia
13%
Immune System
13%
Appendix
10%
Ankylosing Spondylitis
10%
Vasculitis
10%
Atopic Dermatitis
8%
Tonsil
8%
Mucosa
8%
Microflora
8%
Allergic Asthma
8%
Prevalence
8%
Gut-Associated Lymphoid Tissue
8%
Lupus Erythematosus
8%
Autoimmunity
8%
Graves' Disease
8%
Dermatomyositis
6%
Polymyositis
6%
Systemic Scleroderma
6%
Hashimoto's Thyroiditis
5%
